在治疗帕克利塔塞尔诱导的外围神经病变时,新出现的目标和转化挑战
Sivadas Swathi Krishna1, Nandana Shaji1, Nandana V Kumar1
1Amrita School of Nano-sciences and Molecular Medicine, Amrita Vishwa Vidyapeetham, Ponekkara, Kochi, 682041, Kerala, India.
Molecular biology reports
|August 18, 2025
概括
帕克利塔塞尔诱导的周围神经病变 (PIPN) 是常见的化疗副作用. 本综述探讨了新的分子标和新兴疗法,以管理PIPN并改善患者的治疗结果.
科学领域:
- 神经科学是一个神经科学.
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕克利塔塞尔诱导的周围神经病变 (PIPN) 是化疗中显著的剂量限制性毒性,影响高达70%的患者.
- 潜在的机制包括受损的微管力学,线粒体功能障碍,改变的信号和神经炎症.
研究的目的:
- 审查PIPN管理的新兴分子目标.
- 探索用于PIPN.的临床前和临床开发中的新型治疗剂.
主要方法:
- 关于分子和神经学研究近期进展的文献综述.
- 对PIPN.的潜在分子标和治疗策略的识别.
主要成果:
- 确定的关键分子标包括收费类受体 (TLR),短暂受体潜能 (TRP) 通道,PGC-1α和炎症性细胞因子.
- 表观遗传调节器和非编码RNA显示出作为治疗剂的前景.
结论:
- 新的分子标和治疗策略正在出现PIPN.
- 未来针对PIPN管理的个性化治疗策略可以根据这些发现进行指导.
相关概念视频
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Peripheral Artery Disease IV: Nursing Management
43
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
43
Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Peripheral Artery Disease V: Postoperative Nursing Management
25
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
25
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
34
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
34
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


